List view / Grid view
18 June 2015 | By Victoria White
A new drug screening technology developed at the Harvard T.H. Chan School of Public Health has identified a new potential anti-diabetes compound - azoramide...
3 June 2015 | By Victoria White
Auspherix has raised £6 million in a Series A venture financing and is establishing operations on the Stevenage Bioscience Catalyst site...
28 May 2015 | By Victoria White
TSRI scientists have been awarded nearly $2.2 million to advance understanding of IP6K1 and develop innovative approaches for the treatment of obesity...
29 April 2015 | By Victoria White
An international team of scientists has identified a new genetic mutation that appears to protect people from developing Type 2 diabetes...
17 April 2015 | By Victoria White
Novogen and the Feinstein Institute for Medical Research are to collaborate to develop effective treatments for brain cancers...
17 April 2015 | By Victoria White
Takeda and CiRA to work together to develop clinical applications of induced pluripotent stem cells in areas such as diabetes mellitus and immunotherapy...
13 April 2015 | By Victoria White
AstraZeneca and PatientsLikeMe have signed an agreement to provide AZ with access to PatientsLikeMe’s global network to shape future medicine development...
7 April 2015 | By Victoria White
Bristol-Myers Squibb get exclusive access to uniQure’s gene therapy technology platform for multiple targets in cardiovascular diseases...
2 February 2015 | By Imec
The CARDIS project will develop and validate an early-stage cardio vascular disease detection platform using integrated silicon photonics...
29 January 2015 | By Medical Research Council
Minister for Life Sciences George Freeman announced a further £13.7 million investment in stratified medicine collaborations funded by the Medical Research Council (MRC)...
8 January 2015 | By Advanced Accelerator Applications S.A.
Advanced Accelerator Applications S.A. announced that it has acquired the remaining 49.9% of Atreus Pharmaceuticals Corporation, a development-stage biopharmaceutical company headquartered in Ottawa, Canada...
13 November 2014 | By Amgen
Thirteen presentations include new analyses of PCSK9 inhibitor at upcoming American Heart Association Scientific sessions...
11 November 2014 | By Daiichi Sankyo Company
Daiichi Sankyo Company, Limited announced that it has selected research partners for its 2014 TaNeDS (Take a New challenge for Drug diScovery) collaborative drug discovery project...
6 November 2014 | By Cardio3 BioSciences
Cardio3 BioSciences, a leader in the discovery and development of regenerative, protective and reconstructive therapies, announces that it has acquired U.S.-based CorQuest Medical Inc. CorQuest Medical specializes in the development of innovative devices and technologies for cardiac surgery...
14 October 2014 | By Rigontec GmbH
Rigontec GmbH, a privately held biopharmaceutical company developing RNA-based immunotherapeutics for the treatment of cancer and viral diseases, announces the first closing of its Series A financing round, raising €9.45 million...
